img

Global Natural Killer Cells Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Natural Killer Cells Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
Global Natural Killer Cells Therapeutics market is projected to reach US$ 398.5 million in 2033, increasing from US$ 255.8 million in 2022, with the CAGR of 6.4% during the period of 2023 to 2033. Demand from Research Centers & Institutes and Hospitals are the major drivers for the industry.
The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.
Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).
Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Natural Killer Cells Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Affimed
Celgene Corporation
Fate Therapeutics
Fortress Biotech
Glycostem Therapeutics
Innate Pharma
Nantkwest
Nkarta Therapeutics
NKT Therapeutics
Ziopharm Oncology
Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies

Segment by Application


Research Centers & Institutes
Hospitals
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Natural Killer Cells Therapeutics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Natural Killer Cells Therapeutics introduction, etc. Natural Killer Cells Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Natural Killer Cells Therapeutics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Natural Killer Cells Therapeutics
1.1 Natural Killer Cells Therapeutics Market Overview
1.1.1 Natural Killer Cells Therapeutics Product Scope
1.1.2 Natural Killer Cells Therapeutics Market Status and Outlook
1.2 Global Natural Killer Cells Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Natural Killer Cells Therapeutics Market Size by Region (2018-2033)
1.4 Global Natural Killer Cells Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Natural Killer Cells Therapeutics Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Natural Killer Cells Therapeutics Market Size (2018-2033)
1.6.1 North America Natural Killer Cells Therapeutics Market Size (2018-2033)
1.6.2 Europe Natural Killer Cells Therapeutics Market Size (2018-2033)
1.6.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size (2018-2033)
1.6.4 Latin America Natural Killer Cells Therapeutics Market Size (2018-2033)
1.6.5 Middle East & Africa Natural Killer Cells Therapeutics Market Size (2018-2033)
2 Natural Killer Cells Therapeutics Market by Type
2.1 Introduction
2.1.1 NK Cell Therapies
2.1.2 NK Cell Directed Antibodies
2.2 Global Natural Killer Cells Therapeutics Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Natural Killer Cells Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Natural Killer Cells Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Natural Killer Cells Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Natural Killer Cells Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Natural Killer Cells Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Natural Killer Cells Therapeutics Revenue Breakdown by Type (2018-2033)
3 Natural Killer Cells Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Research Centers & Institutes
3.1.2 Hospitals
3.1.3 Others
3.2 Global Natural Killer Cells Therapeutics Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Natural Killer Cells Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Natural Killer Cells Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Natural Killer Cells Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Natural Killer Cells Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Natural Killer Cells Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Natural Killer Cells Therapeutics Revenue Breakdown by Application (2018-2033)
4 Natural Killer Cells Therapeutics Competition Analysis by Players
4.1 Global Natural Killer Cells Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2022)
4.3 Date of Key Players Enter into Natural Killer Cells Therapeutics Market
4.4 Global Top Players Natural Killer Cells Therapeutics Headquarters and Area Served
4.5 Key Players Natural Killer Cells Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Natural Killer Cells Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Affimed
5.1.1 Affimed Profile
5.1.2 Affimed Main Business
5.1.3 Affimed Natural Killer Cells Therapeutics Products, Services and Solutions
5.1.4 Affimed Natural Killer Cells Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Affimed Recent Developments
5.2 Celgene Corporation
5.2.1 Celgene Corporation Profile
5.2.2 Celgene Corporation Main Business
5.2.3 Celgene Corporation Natural Killer Cells Therapeutics Products, Services and Solutions
5.2.4 Celgene Corporation Natural Killer Cells Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Celgene Corporation Recent Developments
5.3 Fate Therapeutics
5.3.1 Fate Therapeutics Profile
5.3.2 Fate Therapeutics Main Business
5.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Products, Services and Solutions
5.3.4 Fate Therapeutics Natural Killer Cells Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Fortress Biotech Recent Developments
5.4 Fortress Biotech
5.4.1 Fortress Biotech Profile
5.4.2 Fortress Biotech Main Business
5.4.3 Fortress Biotech Natural Killer Cells Therapeutics Products, Services and Solutions
5.4.4 Fortress Biotech Natural Killer Cells Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Fortress Biotech Recent Developments
5.5 Glycostem Therapeutics
5.5.1 Glycostem Therapeutics Profile
5.5.2 Glycostem Therapeutics Main Business
5.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Products, Services and Solutions
5.5.4 Glycostem Therapeutics Natural Killer Cells Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Glycostem Therapeutics Recent Developments
5.6 Innate Pharma
5.6.1 Innate Pharma Profile
5.6.2 Innate Pharma Main Business
5.6.3 Innate Pharma Natural Killer Cells Therapeutics Products, Services and Solutions
5.6.4 Innate Pharma Natural Killer Cells Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Innate Pharma Recent Developments
5.7 Nantkwest
5.7.1 Nantkwest Profile
5.7.2 Nantkwest Main Business
5.7.3 Nantkwest Natural Killer Cells Therapeutics Products, Services and Solutions
5.7.4 Nantkwest Natural Killer Cells Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Nantkwest Recent Developments
5.8 Nkarta Therapeutics
5.8.1 Nkarta Therapeutics Profile
5.8.2 Nkarta Therapeutics Main Business
5.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Products, Services and Solutions
5.8.4 Nkarta Therapeutics Natural Killer Cells Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Nkarta Therapeutics Recent Developments
5.9 NKT Therapeutics
5.9.1 NKT Therapeutics Profile
5.9.2 NKT Therapeutics Main Business
5.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Products, Services and Solutions
5.9.4 NKT Therapeutics Natural Killer Cells Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 NKT Therapeutics Recent Developments
5.10 Ziopharm Oncology
5.10.1 Ziopharm Oncology Profile
5.10.2 Ziopharm Oncology Main Business
5.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Products, Services and Solutions
5.10.4 Ziopharm Oncology Natural Killer Cells Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Ziopharm Oncology Recent Developments
6 North America
6.1 North America Natural Killer Cells Therapeutics Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Natural Killer Cells Therapeutics Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Natural Killer Cells Therapeutics Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Natural Killer Cells Therapeutics Market Dynamics
11.1 Natural Killer Cells Therapeutics Industry Trends
11.2 Natural Killer Cells Therapeutics Market Drivers
11.3 Natural Killer Cells Therapeutics Market Challenges
11.4 Natural Killer Cells Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Natural Killer Cells Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Natural Killer Cells Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Natural Killer Cells Therapeutics Market Size Share by Region (2018-2023)
Table 4. Global Natural Killer Cells Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Natural Killer Cells Therapeutics Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Natural Killer Cells Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Natural Killer Cells Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2018-2023)
Table 9. Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2024-2033)
Table 11. North America Natural Killer Cells Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Natural Killer Cells Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Natural Killer Cells Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Natural Killer Cells Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Natural Killer Cells Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Natural Killer Cells Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Natural Killer Cells Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Natural Killer Cells Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Natural Killer Cells Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Natural Killer Cells Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Natural Killer Cells Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Natural Killer Cells Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2018-2023)
Table 24. Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2024-2033)
Table 26. North America Natural Killer Cells Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Natural Killer Cells Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Natural Killer Cells Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Natural Killer Cells Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Natural Killer Cells Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Natural Killer Cells Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Natural Killer Cells Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Natural Killer Cells Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Natural Killer Cells Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Natural Killer Cells Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Natural Killer Cells Therapeutics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Natural Killer Cells Therapeutics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2022)
Table 39. Date of Key Players Enter into Natural Killer Cells Therapeutics Market
Table 40. Global Natural Killer Cells Therapeutics Key Players Headquarters and Area Served
Table 41. Natural Killer Cells Therapeutics Product Solution and Service
Table 42. Global Natural Killer Cells Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Affimed Basic Information List
Table 45. Affimed Description and Business Overview
Table 46. Affimed Natural Killer Cells Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Natural Killer Cells Therapeutics Business of Affimed (2018-2023)
Table 48. Affimed Recent Developments
Table 49. Celgene Corporation Basic Information List
Table 50. Celgene Corporation Description and Business Overview
Table 51. Celgene Corporation Natural Killer Cells Therapeutics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Natural Killer Cells Therapeutics Business of Celgene Corporation (2018-2023)
Table 53. Celgene Corporation Recent Developments
Table 54. Fate Therapeutics Basic Information List
Table 55. Fate Therapeutics Description and Business Overview
Table 56. Fate Therapeutics Natural Killer Cells Therapeutics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Natural Killer Cells Therapeutics Business of Fate Therapeutics (2018-2023)
Table 58. Fate Therapeutics Recent Developments
Table 59. Fortress Biotech Basic Information List
Table 60. Fortress Biotech Description and Business Overview
Table 61. Fortress Biotech Natural Killer Cells Therapeutics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Natural Killer Cells Therapeutics Business of Fortress Biotech (2018-2023)
Table 63. Fortress Biotech Recent Developments
Table 64. Glycostem Therapeutics Basic Information List
Table 65. Glycostem Therapeutics Description and Business Overview
Table 66. Glycostem Therapeutics Natural Killer Cells Therapeutics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Natural Killer Cells Therapeutics Business of Glycostem Therapeutics (2018-2023)
Table 68. Glycostem Therapeutics Recent Developments
Table 69. Innate Pharma Basic Information List
Table 70. Innate Pharma Description and Business Overview
Table 71. Innate Pharma Natural Killer Cells Therapeutics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Natural Killer Cells Therapeutics Business of Innate Pharma (2018-2023)
Table 73. Innate Pharma Recent Developments
Table 74. Nantkwest Basic Information List
Table 75. Nantkwest Description and Business Overview
Table 76. Nantkwest Natural Killer Cells Therapeutics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Natural Killer Cells Therapeutics Business of Nantkwest (2018-2023)
Table 78. Nantkwest Recent Developments
Table 79. Nkarta Therapeutics Basic Information List
Table 80. Nkarta Therapeutics Description and Business Overview
Table 81. Nkarta Therapeutics Natural Killer Cells Therapeutics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Natural Killer Cells Therapeutics Business of Nkarta Therapeutics (2018-2023)
Table 83. Nkarta Therapeutics Recent Developments
Table 84. NKT Therapeutics Basic Information List
Table 85. NKT Therapeutics Description and Business Overview
Table 86. NKT Therapeutics Natural Killer Cells Therapeutics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Natural Killer Cells Therapeutics Business of NKT Therapeutics (2018-2023)
Table 88. NKT Therapeutics Recent Developments
Table 89. Ziopharm Oncology Basic Information List
Table 90. Ziopharm Oncology Description and Business Overview
Table 91. Ziopharm Oncology Natural Killer Cells Therapeutics Products, Services and Solutions
Table 92. Revenue (US$ Million) in Natural Killer Cells Therapeutics Business of Ziopharm Oncology (2018-2023)
Table 93. Ziopharm Oncology Recent Developments
Table 94. North America Natural Killer Cells Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 95. North America Natural Killer Cells Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 96. Europe Natural Killer Cells Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 97. Europe Natural Killer Cells Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 98. Asia-Pacific Natural Killer Cells Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 99. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 100. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 101. Asia-Pacific Natural Killer Cells Therapeutics Market Share by Region (2018-2023)
Table 102. Asia-Pacific Natural Killer Cells Therapeutics Market Share by Region (2024-2033)
Table 103. Latin America Natural Killer Cells Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 104. Latin America Natural Killer Cells Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 105. Latin America Natural Killer Cells Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 106. Middle East & Africa Natural Killer Cells Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 107. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 108. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 109. Natural Killer Cells Therapeutics Market Trends
Table 110. Natural Killer Cells Therapeutics Market Drivers
Table 111. Natural Killer Cells Therapeutics Market Challenges
Table 112. Natural Killer Cells Therapeutics Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Natural Killer Cells Therapeutics Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Natural Killer Cells Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Natural Killer Cells Therapeutics Market Share by Regions: 2022 VS 2033
Figure 4. Global Natural Killer Cells Therapeutics Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Natural Killer Cells Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Natural Killer Cells Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Natural Killer Cells Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Natural Killer Cells Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Natural Killer Cells Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of NK Cell Therapies
Figure 11. Global NK Cell Therapies Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of NK Cell Directed Antibodies
Figure 13. Global NK Cell Directed Antibodies Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Natural Killer Cells Therapeutics Market Size Share by Type: 2022 & 2033
Figure 15. North America Natural Killer Cells Therapeutics Revenue Market Share by Type (2018-2033)
Figure 16. Europe Natural Killer Cells Therapeutics Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Natural Killer Cells Therapeutics Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Natural Killer Cells Therapeutics Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Natural Killer Cells Therapeutics Revenue Market Share by Type (2018-2033)
Figure 20. Research Centers & Institutes Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Hospitals Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Global Natural Killer Cells Therapeutics Market Size Share by Application: 2022 & 2033
Figure 24. North America Natural Killer Cells Therapeutics Revenue Market Share by Application (2018-2033)
Figure 25. Europe Natural Killer Cells Therapeutics Revenue Market Share by Application (2018-2033)
Figure 26. Asia-Pacific Natural Killer Cells Therapeutics Revenue Market Share by Application (2018-2033)
Figure 27. Latin America Natural Killer Cells Therapeutics Revenue Market Share by Application (2018-2033)
Figure 28. Middle East and Africa Natural Killer Cells Therapeutics Revenue Market Share by Application (2018-2033)
Figure 29. Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Natural Killer Cells Therapeutics Market Share in 2022
Figure 31. North America Natural Killer Cells Therapeutics Market Share by Country (2018-2033)
Figure 32. U.S. Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 33. Canada Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 34. Germany Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 35. France Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 36. U.K. Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 37. Italy Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 38. Russia Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 39. Nordic Countries Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 40. Asia-Pacific Natural Killer Cells Therapeutics Market Share by Region (2018-2033)
Figure 41. China Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 42. Japan Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 43. South Korea Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 45. India Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 46. Australia Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 47. Latin America Natural Killer Cells Therapeutics Market Share by Country (2018-2033)
Figure 48. Mexico Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 49. Brazil Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Natural Killer Cells Therapeutics Market Share by Country (2018-2033)
Figure 51. Turkey Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 53. UAE Natural Killer Cells Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report